Bristol-Myers Squibb Uncategorized Contracts & Agreements

66 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Bristol-Myers Squibb Company
Bristol-Myers Squibb
Pharmaceuticals
NY
2023
Description of Bristol-Myers Squibb Company
Bristol-Myers Squibb
Pharmaceuticals
NY
2022
Bristol-Myers Squibb Company Benefit Equalization Plan Savings and Investment Program, effective as of January 1, 2012 and as amended and restated effective as of January 1, 2020
Bristol-Myers Squibb
Pharmaceuticals
2021
Description of Bristol-Myers Squibb Company
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Letter Agreement between Bristol-Myers Squibb Company and Mr. David Elkins, dated as of May 30, 2019
Bristol-Myers Squibb
Pharmaceuticals
2020
Description of Bristol-Myers Squibb Company's securities registered pursuant to Section 12 of the Securities Exchange Act of 1934
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Contingent Value Rights Agreement, dated as of November 20, 2019, by and between Bristol-Myers Squibb Company and Equiniti Trust Company, as trustee, including the Form of CVR...
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Letter Agreement between Bristol-Myers Squibb Company and Dr. Thomas J. Lynch, Jr., dated as of June 4, 2019
Bristol-Myers Squibb
Pharmaceuticals
NJ
2019
Form of Contingent Value Rights Agreement, between Bristol-Myers Squibb Company and the Trustee (as defined therein)
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
AMENDMENT
Bristol-Myers Squibb
Pharmaceuticals
VA
2016
Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
Bristol-Myers Squibb
Pharmaceuticals
2015
Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
Bristol-Myers Squibb
Pharmaceuticals
2015
Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
Bristol-Myers Squibb
Pharmaceuticals
2014
Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
Bristol-Myers Squibb
Pharmaceuticals
2014
Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
Bristol-Myers Squibb
Pharmaceuticals
2013
Bristol-Myers Squibb Company 345 Park Avenue New York, New York 10154
Bristol-Myers Squibb
Pharmaceuticals
2013
BRISTOL-MYERS SQUIBB COMPANY BENEFIT EQUALIZATION PLANSAVINGS ANDINVESTMENT PROGRAM (as amended and restated effective as of January 1, 2012) TABLE OF CONTENTS
Bristol-Myers Squibb
Pharmaceuticals
2013
BRISTOL-MYERS SQUIBB COMPANY BENEFIT EQUALIZATION PLANRETIREMENT INCOMEPLAN (as amended and restated effective as of January 1, 2012) TABLE OF CONTENTS
Bristol-Myers Squibb
Pharmaceuticals
2013
*Confidential Treatment Requested AMENDMENT TO OTSUKA-BMSABILIFY AGREEMENTS
Bristol-Myers Squibb
Pharmaceuticals
2013
*Confidential Treatment Requested AMENDMENT NO. 4 TO THE TERRITORY B ALLIANCE SUPPORT AGREEMENT
Bristol-Myers Squibb
Pharmaceuticals
2013
*Confidential Treatment Requested AMENDMENT TO THE PARTNERSHIP AGREEMENT OF BRISTOL-MYERS SQUIBB SANOFI PHARMACEUTICALS HOLDING PARTNERSHIP
Bristol-Myers Squibb
Pharmaceuticals
2013
*Confidential Treatment Requested This text is a freetranslation from the French language and is supplied solely for information purposes. Only the original version in theFrench...
Bristol-Myers Squibb
Pharmaceuticals
2013
*Confidential Treatment Requested
Bristol-Myers Squibb
Pharmaceuticals
2013
($791,582)
Bristol-Myers Squibb
Pharmaceuticals
NJ
2012
MEAD JOHNSON NUTRITION COMPANY, MEAD JOHNSON & COMPANY AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., TRUSTEE
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
NY
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION
Bristol-Myers Squibb
Pharmaceuticals
DE
2009
* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION This text is a free translation from the French...
Bristol-Myers Squibb
Pharmaceuticals
2009
This text is a free translation from the French language and is supplied solely for information purposes. Only the original version in the French language has legal force.
Bristol-Myers Squibb
Pharmaceuticals
2009
E-10-2
Bristol-Myers Squibb
Pharmaceuticals
2009
AMENDED AND RESTATED AIRCRAFT TIME SHARING AGREEMENT
Bristol-Myers Squibb
Pharmaceuticals
2008
BRISTOL-MYERS SQUIBB COMPANY
Bristol-Myers Squibb
Pharmaceuticals
NY
2008
Page 1 of 13
Bristol-Myers Squibb
Pharmaceuticals
NY
2008